Annals of Internal Medicine: Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial Guest UserJanuary 8, 2019 Facebook0 Twitter LinkedIn0 0 Likes